Shenzhen Transsion Holdings Co., Ltd. (SHA:688036)
China · Delayed Price · Currency is CNY 57.75
-0.69 (-1.18%)
Apr 30, 2026, 3:00 PM CST
SHA:688036 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 67,722 | 64,526 | 67,456 | 61,320 | 45,927 | 48,536 |
Other Revenue | 1,065 | 1,065 | 1,259 | 975.21 | 668.47 | 875.78 |
| 68,788 | 65,591 | 68,715 | 62,295 | 46,596 | 49,412 | |
Revenue Growth (YoY) | 7.02% | -4.55% | 10.31% | 33.69% | -5.70% | 30.75% |
Cost of Revenue | 55,450 | 53,313 | 54,374 | 47,855 | 36,854 | 39,095 |
Gross Profit | 13,337 | 12,278 | 14,341 | 14,440 | 9,742 | 10,317 |
Selling, General & Admin | 7,031 | 6,882 | 6,569 | 5,836 | 4,891 | 4,540 |
Research & Development | 3,132 | 2,950 | 2,517 | 2,256 | 2,078 | 1,511 |
Other Operating Expenses | -11.47 | 11.69 | -39.69 | 113.35 | 24.95 | 3.42 |
Operating Expenses | 10,240 | 9,879 | 9,064 | 8,259 | 7,036 | 6,062 |
Operating Income | 3,098 | 2,399 | 5,277 | 6,181 | 2,706 | 4,255 |
Interest Expense | -70.32 | -68.41 | -81.97 | -79.27 | -66.85 | -36.87 |
Interest & Investment Income | 938.51 | 944.15 | 1,115 | 498.81 | 158.14 | 167.54 |
Currency Exchange Gain (Loss) | -309.91 | -309.91 | -74.9 | 3.58 | 74.55 | -192.77 |
Other Non Operating Income (Expenses) | -213.73 | -40.48 | -35.99 | -77.8 | -45.99 | -72.06 |
EBT Excluding Unusual Items | 3,442 | 2,924 | 6,199 | 6,526 | 2,826 | 4,121 |
Gain (Loss) on Sale of Investments | -146.71 | -20.67 | -156.72 | -68.16 | -155.25 | 418.83 |
Gain (Loss) on Sale of Assets | 0.93 | 3.88 | -1.99 | -0.74 | -0.19 | 3.91 |
Asset Writedown | -83.68 | -0.09 | -0.9 | -0.64 | -0.29 | -0.45 |
Other Unusual Items | 275.4 | 275.4 | 638.04 | 257.79 | 323.67 | 234.79 |
Pretax Income | 3,488 | 3,183 | 6,678 | 6,714 | 2,993 | 4,778 |
Income Tax Expense | 638.43 | 577.59 | 1,080 | 1,127 | 526.68 | 866.28 |
Earnings From Continuing Operations | 2,850 | 2,605 | 5,597 | 5,587 | 2,467 | 3,912 |
Minority Interest in Earnings | -58.93 | -24.6 | -48.38 | -50.02 | 16.96 | -2.34 |
Net Income | 2,791 | 2,581 | 5,549 | 5,537 | 2,484 | 3,909 |
Net Income to Common | 2,791 | 2,581 | 5,549 | 5,537 | 2,484 | 3,909 |
Net Income Growth | -36.75% | -53.49% | 0.21% | 122.93% | -36.46% | 45.52% |
Shares Outstanding (Basic) | 1,144 | 1,142 | 1,132 | 1,128 | 1,125 | 1,122 |
Shares Outstanding (Diluted) | 1,149 | 1,147 | 1,144 | 1,137 | 1,129 | 1,126 |
Shares Change (YoY) | 0.38% | 0.25% | 0.63% | 0.71% | 0.25% | 0.31% |
EPS (Basic) | 2.44 | 2.26 | 4.90 | 4.91 | 2.21 | 3.49 |
EPS (Diluted) | 2.43 | 2.25 | 4.85 | 4.87 | 2.20 | 3.47 |
EPS Growth | -36.99% | -53.61% | -0.41% | 121.36% | -36.63% | 45.07% |
Free Cash Flow | -3,065 | 437.07 | 2,208 | 11,067 | 1,139 | 3,298 |
Free Cash Flow Per Share | -2.67 | 0.38 | 1.93 | 9.73 | 1.01 | 2.93 |
Dividend Per Share | 1.700 | 1.700 | 3.000 | 4.286 | 1.286 | 1.071 |
Dividend Growth | -43.33% | -43.33% | -30.00% | 233.34% | 20.00% | 38.89% |
Gross Margin | 19.39% | 18.72% | 20.87% | 23.18% | 20.91% | 20.88% |
Operating Margin | 4.50% | 3.66% | 7.68% | 9.92% | 5.81% | 8.61% |
Profit Margin | 4.06% | 3.93% | 8.08% | 8.89% | 5.33% | 7.91% |
Free Cash Flow Margin | -4.46% | 0.67% | 3.21% | 17.77% | 2.44% | 6.68% |
EBITDA | 3,397 | 2,697 | 5,573 | 6,393 | 2,855 | 4,381 |
EBITDA Margin | 4.94% | 4.11% | 8.11% | 10.26% | 6.13% | 8.87% |
D&A For EBITDA | 298.72 | 298.16 | 295.92 | 211.76 | 148.85 | 126.27 |
EBIT | 3,098 | 2,399 | 5,277 | 6,181 | 2,706 | 4,255 |
EBIT Margin | 4.50% | 3.66% | 7.68% | 9.92% | 5.81% | 8.61% |
Effective Tax Rate | 18.30% | 18.15% | 16.18% | 16.79% | 17.59% | 18.13% |
Revenue as Reported | 68,788 | 65,591 | 68,715 | 62,295 | 46,596 | 49,412 |
Advertising Expenses | - | 3,267 | 3,123 | 2,799 | - | 1,407 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.